title: [Adaptation and validation of a brief screening questionnaire of depressive disorders in patients with cancer: Q2i study].
abstract: BACKGROUND
  Depression is a sustainable state of deep sadness and abatement. It is frequently identified in patients with cancer and often undervalued by oncologists. The reduced PRIME-MD questionnaire is a questionnaire of 2 items validated in French. However, it has been neither translated nor validated in French. The objective of our study is to translate the PRIME-MD and validate it into French.
  
  
  METHODS
  The PRIME-MD questionnaire was translated into French by using the recommendations of the EORTC and compared to the French gold standard questionnaire Mini-International Neuropsychiatric Interview (MINI).
  
  
  RESULTS
  Two hundred and ninety-nine patients were included in our study. With a 98% filling rate, the Q2i questionnaire has been well accepted. The prevalence of depression in our population was measured at 7.4%. With a sensitivity of 89.47%, a specificity of 58.85%, found percentages are equal to those of the questionnaire in English. The negative predictive value was measured at 98.52%.
  
  
  CONCLUSIONS
  This study demonstrates that the Q2i questionnaire is a quick and easy screening tool, requiring less than 2minutes to target patients likely to benefit from psychological support.
authors.affiliation: Centre Antoine-Lacassagne, département oncologie médicale, 06189 Nice, France.
authors.forename: Jérôme
authors.initials: J
authors.lastname: Barriere
authors.affiliation: Centre Antoine-Lacassagne, département oncologie médicale, 06189 Nice, France.
authors.forename: Véronique
authors.initials: V
authors.lastname: Mari
authors.affiliation: CHU, pôle neurosciences clinique, 06200 Nice, France.
authors.forename: Faredj
authors.initials: F
authors.lastname: Cherikh
authors.affiliation: Centre azuréen de cancérologie, département d'oncologie médicale, 06250 Mougins, France.
authors.forename: Remi
authors.initials: R
authors.lastname: Largillier
authors.affiliation: Centre Antoine-Lacassagne, département recherche clique et innovation, unité d'épidémiologie et biostatistiques, 06189 Nice, France.
authors.forename: Marc
authors.initials: M
authors.lastname: Ettaiche
authors.affiliation: Centre Antoine-Lacassagne, département recherche clique et innovation, unité d'épidémiologie et biostatistiques, 06189 Nice, France.
authors.forename: Renaud
authors.initials: R
authors.lastname: Schiappa
authors.affiliation: Centre Antoine-Lacassagne, département recherche clique et innovation, unité d'épidémiologie et biostatistiques, 06189 Nice, France.
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Chamorey
authors.affiliation: Centre Antoine-Lacassagne, département recherche clique et innovation, unité d'épidémiologie et biostatistiques, 06189 Nice, France.
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Ferrero
authors.affiliation: Centre Antoine-Lacassagne, département recherche clique et innovation, unité d'épidémiologie et biostatistiques, 06189 Nice, France. Electronic address: jocelyn.gal@nice.unicancer.fr.
authors.forename: Jocelyn
authors.initials: J
authors.lastname: Gal
mesh_terms: D003866:Depressive Disorder / Q000175:diagnosis* / Q000453:epidemiology; D005260:Female; D006801:Humans; D007406:Interview, Psychological; D007802:Language; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000523:psychology*; D011788:Quality of Life; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D011795:Surveys and Questionnaires; D013997:Time Factors; D014177:Translations
keywords: Depression; Dépistage; Dépression; Oncologie; Oncology; Questionnaire court; Screening; Short questionnaire